• Member of the Board of Organon & Co., Inc.
• Member of the Board of Edwards Lifesciences Corporation.
• Member of the Board of Trustees, University Health Network, Toronto..

• President, Global Portfolio Division of Takeda Pharmaceutical Company Limited, 2022-2025.
• President, US Business Unit and Global Product Launch Strategy and Commercialization for Takeda, 2015-2022.
• Employed in Eli Lilly and Company in various leadership roles across Canada, Europe and the US, in the final years as Vice President, Lilly USA, 1994-2015.

• Considered independent under the Danish Corporate Governance Recommendations.
• Member of the Remuneration Committee since 2026.
• Member of the Research & Development Committee since 2026.

• Global corporate leadership.
• Healthcare & pharma industry.
• Business development, M&A and external innovation sourcing.
• Medicine & science.
• Human capital management.

• 1991 MBA from McMaster University, Canada.
• 1988 BS, Molecular Genetics and Molecular Biology from University of Toronto, Canada.

Canadian. Born in 1965. Female.